Oxford Textbook of Sjögren's Syndrome
Herausgeber: Price, Elizabeth J; Tappuni, Anwar R
Oxford Textbook of Sjögren's Syndrome
Herausgeber: Price, Elizabeth J; Tappuni, Anwar R
- Gebundenes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
Oxford Textbook of Sjögren's Syndrome is an authoritative resource for everyday practice and reference. Suitable for rheumatologists, ophthalmologists, oral physicians, specialist nurses, neurologists, oncologists, general medics, and dentists.
Andere Kunden interessierten sich auch für
- Oxford Textbook of Psoriatic Arthritis189,99 €
- Oxford Textbook of Rheumatoid Arthritis207,99 €
- Oxford Textbook of Rheumatology736,99 €
- Oxford Textbook of Neuropsychiatry201,99 €
- Oxford Textbook of Pediatric Pain238,99 €
- Oxford Textbook of Sleep Disorders234,99 €
- Oxford Textbook of Attention Deficit Hyperactivity Disorder201,99 €
-
-
-
Oxford Textbook of Sjögren's Syndrome is an authoritative resource for everyday practice and reference. Suitable for rheumatologists, ophthalmologists, oral physicians, specialist nurses, neurologists, oncologists, general medics, and dentists.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Produktdetails
- Produktdetails
- Verlag: Hurst & Co.
- Seitenzahl: 288
- Erscheinungstermin: 11. Mai 2021
- Englisch
- Abmessung: 277mm x 226mm x 23mm
- Gewicht: 1066g
- ISBN-13: 9780198806684
- ISBN-10: 019880668X
- Artikelnr.: 59999241
- Verlag: Hurst & Co.
- Seitenzahl: 288
- Erscheinungstermin: 11. Mai 2021
- Englisch
- Abmessung: 277mm x 226mm x 23mm
- Gewicht: 1066g
- ISBN-13: 9780198806684
- ISBN-10: 019880668X
- Artikelnr.: 59999241
Dr Elizabeth J Price is a consultant rheumatologist who has a specific interest in Sjogren's Syndrome and runs a specialist Sjogren's clinic at the Great Western Hospital in Swindon. Her interest in Sjogren's dates from her Research Fellowship at The Kennedy Institute in London where she completed an MD thesis focusing on Sjogren's syndrome. She currently focuses on extraglandular manifestations of the disease and clinical research into SS and was the lead author and driving force behind the BSR Guidelines for the management of Sjogren's syndrome. Professor Anwar R Tappuni is a consultant in Oral Medicine with a special interest in the head and neck manifestations of Sjogren's syndrome. She leads a multidisciplinary clinic for Sjogren's syndrome patients at the Institute of Dentistry, Barts Health NHS Trust. Her team has produced impactful basic science and translational research, published in internationally renowned scientific journals. Professor Tappuni is the founder and director of the Doctorate in Clinical Dentistry in Oral Medicine programme at Queen Mary University of London. She was the lead author on the oral section of the NICE approved BSR Guidelines for the management of Sjogren's syndrome.
* Section 1: Introduction
* 1.1: Elizabeth J. Price and Anwar R. Tappuni: Introduction
* 1.2: Caroline Shiboski and Troy E. Daniels: Historical background,
classification and diagnostic criteria
* 1.3: Simon Bowman: Epidemiology and genetics of Sjögren s Syndrome
* Section 2: Basic science
* 2.1: Onorina Berardicurti, Charlotte G. Smith, Roberto Giacomelli,
Elizabeth J. Price, and Francesca Barone: Biomarkers in primary
Sjögren sSyndrome
* 2.2: Aurélie Ambrosi, Albin Björk, and Marie Wahren-Herlenius:
Autoantibodies and autoantigens in Sjögren s Syndrome
* 2.3: Saba Nayar, Serena Colafrancesco, and Francesca Barone: Stromal
cells in Sjögren s Syndrome
* Section 3: Diagnostic investigations
* 3.1: Anwar R. Tappuni: Clinical assessment of salivary glands
function
* 3.2: Benjamin Fisher: Biopsy gland biopsy procedure and
histopathology
* 3.3: Ashok Adams: Imaging in Sjögren s Syndrome
* Section 4: Head and neck manifestations and clinical management
* 4.1: Emily Carter: Salivary glands manifestations and management
* 4.2: Anwar R. Tappuni: Oral manifestations and management
* 4.3: Jennifer Fuller and Shakeel Shahdad: Dental related disease
* Section 5: Ocular manifestations and management
* 5.1: Nicola Roper, Pasquale Aragona, Maurizio Rolando, and Francisco
C Figueiredo: Ocular Manifestations of Sjögren s Syndrome
* 5.2: Nicola Roper, Pasquale Aragona, Maurizio Rolando, and Francisco
C Figueiredo: A therapeutic strategy for Sjögren s Syndrome dry eye
* Section 6: Systemic manifestations
* 6.1: Thomas J Tull, Emma Benton, and David D Cruz: Cutaneous
involvement and management of Sjögren s Syndrome
* 6.2: Elizabeth J. Price: Musculoskeletal disease - presentation and
management
* 6.3: Rhys Evans and Stephen Walsh: Renal involvement in Primary
Sjögren's Syndrome
* 6.4: Elizabeth J. Price: Gastrointestinal Disease in Sjögren s
syndrome
* 6.5: Aravind Ganesh, Shane Lyons, and Gabriel Yiin: Neurological
complications of Sjögren s Syndrome
* 6.6: Sara Carty: Cardiovascular and Lung Manifestations of Sjögren s
Syndrome
* 6.7: Coziana Ciurtin and Su-Ann Yeoh: Haematological Manifestations
of Sjögren s Syndrome
* 6.8: Coziana Ciurtin and Su-Ann Yeoh: Fatigue in Sjögren s Syndrome
* 6.9: Katie Hackett and Helen Cartner: Non-pharmacological
interventions for the management of Fatigue and Constitutional
Symptoms in Sjögren s Syndrome
* 6.1: Roberta Priori, Antonina Minniti, and Serena Colafrancesco:
Gynaecologic and obstetric aspects in Sjögren s Syndrome
* 6.11: Saad Rassam: Sjögren s Syndrome Associated Lymphoma
* Section 7: Juvenile and young adult
* 7.1: William D. Renton, Elizabeth J. Price, and A.V. Ramanan:
Juvenile and young adult onset Sjögren s Syndrome
* Section 8: Sjogren s mimics and overlaps
* 8.1: Nurhan Sutcliffe: Mimics of Sjögren s Syndrome
* 8.2: Nurhan Sutcliffe and Arabella Waller: Sjögren s Syndrome
overlaps
* Section 9: Experimental treatments, emerging therapies and the future
* 9.1: Benjamin Fisher: Experimental therapies in primary Sjögren s
Syndrome
* 9.2: Elizabeth J. Price and Alan Baer: Sjögren s Syndrome Summary of
Clinical Management
* 1.1: Elizabeth J. Price and Anwar R. Tappuni: Introduction
* 1.2: Caroline Shiboski and Troy E. Daniels: Historical background,
classification and diagnostic criteria
* 1.3: Simon Bowman: Epidemiology and genetics of Sjögren s Syndrome
* Section 2: Basic science
* 2.1: Onorina Berardicurti, Charlotte G. Smith, Roberto Giacomelli,
Elizabeth J. Price, and Francesca Barone: Biomarkers in primary
Sjögren sSyndrome
* 2.2: Aurélie Ambrosi, Albin Björk, and Marie Wahren-Herlenius:
Autoantibodies and autoantigens in Sjögren s Syndrome
* 2.3: Saba Nayar, Serena Colafrancesco, and Francesca Barone: Stromal
cells in Sjögren s Syndrome
* Section 3: Diagnostic investigations
* 3.1: Anwar R. Tappuni: Clinical assessment of salivary glands
function
* 3.2: Benjamin Fisher: Biopsy gland biopsy procedure and
histopathology
* 3.3: Ashok Adams: Imaging in Sjögren s Syndrome
* Section 4: Head and neck manifestations and clinical management
* 4.1: Emily Carter: Salivary glands manifestations and management
* 4.2: Anwar R. Tappuni: Oral manifestations and management
* 4.3: Jennifer Fuller and Shakeel Shahdad: Dental related disease
* Section 5: Ocular manifestations and management
* 5.1: Nicola Roper, Pasquale Aragona, Maurizio Rolando, and Francisco
C Figueiredo: Ocular Manifestations of Sjögren s Syndrome
* 5.2: Nicola Roper, Pasquale Aragona, Maurizio Rolando, and Francisco
C Figueiredo: A therapeutic strategy for Sjögren s Syndrome dry eye
* Section 6: Systemic manifestations
* 6.1: Thomas J Tull, Emma Benton, and David D Cruz: Cutaneous
involvement and management of Sjögren s Syndrome
* 6.2: Elizabeth J. Price: Musculoskeletal disease - presentation and
management
* 6.3: Rhys Evans and Stephen Walsh: Renal involvement in Primary
Sjögren's Syndrome
* 6.4: Elizabeth J. Price: Gastrointestinal Disease in Sjögren s
syndrome
* 6.5: Aravind Ganesh, Shane Lyons, and Gabriel Yiin: Neurological
complications of Sjögren s Syndrome
* 6.6: Sara Carty: Cardiovascular and Lung Manifestations of Sjögren s
Syndrome
* 6.7: Coziana Ciurtin and Su-Ann Yeoh: Haematological Manifestations
of Sjögren s Syndrome
* 6.8: Coziana Ciurtin and Su-Ann Yeoh: Fatigue in Sjögren s Syndrome
* 6.9: Katie Hackett and Helen Cartner: Non-pharmacological
interventions for the management of Fatigue and Constitutional
Symptoms in Sjögren s Syndrome
* 6.1: Roberta Priori, Antonina Minniti, and Serena Colafrancesco:
Gynaecologic and obstetric aspects in Sjögren s Syndrome
* 6.11: Saad Rassam: Sjögren s Syndrome Associated Lymphoma
* Section 7: Juvenile and young adult
* 7.1: William D. Renton, Elizabeth J. Price, and A.V. Ramanan:
Juvenile and young adult onset Sjögren s Syndrome
* Section 8: Sjogren s mimics and overlaps
* 8.1: Nurhan Sutcliffe: Mimics of Sjögren s Syndrome
* 8.2: Nurhan Sutcliffe and Arabella Waller: Sjögren s Syndrome
overlaps
* Section 9: Experimental treatments, emerging therapies and the future
* 9.1: Benjamin Fisher: Experimental therapies in primary Sjögren s
Syndrome
* 9.2: Elizabeth J. Price and Alan Baer: Sjögren s Syndrome Summary of
Clinical Management
* Section 1: Introduction
* 1.1: Elizabeth J. Price and Anwar R. Tappuni: Introduction
* 1.2: Caroline Shiboski and Troy E. Daniels: Historical background,
classification and diagnostic criteria
* 1.3: Simon Bowman: Epidemiology and genetics of Sjögren s Syndrome
* Section 2: Basic science
* 2.1: Onorina Berardicurti, Charlotte G. Smith, Roberto Giacomelli,
Elizabeth J. Price, and Francesca Barone: Biomarkers in primary
Sjögren sSyndrome
* 2.2: Aurélie Ambrosi, Albin Björk, and Marie Wahren-Herlenius:
Autoantibodies and autoantigens in Sjögren s Syndrome
* 2.3: Saba Nayar, Serena Colafrancesco, and Francesca Barone: Stromal
cells in Sjögren s Syndrome
* Section 3: Diagnostic investigations
* 3.1: Anwar R. Tappuni: Clinical assessment of salivary glands
function
* 3.2: Benjamin Fisher: Biopsy gland biopsy procedure and
histopathology
* 3.3: Ashok Adams: Imaging in Sjögren s Syndrome
* Section 4: Head and neck manifestations and clinical management
* 4.1: Emily Carter: Salivary glands manifestations and management
* 4.2: Anwar R. Tappuni: Oral manifestations and management
* 4.3: Jennifer Fuller and Shakeel Shahdad: Dental related disease
* Section 5: Ocular manifestations and management
* 5.1: Nicola Roper, Pasquale Aragona, Maurizio Rolando, and Francisco
C Figueiredo: Ocular Manifestations of Sjögren s Syndrome
* 5.2: Nicola Roper, Pasquale Aragona, Maurizio Rolando, and Francisco
C Figueiredo: A therapeutic strategy for Sjögren s Syndrome dry eye
* Section 6: Systemic manifestations
* 6.1: Thomas J Tull, Emma Benton, and David D Cruz: Cutaneous
involvement and management of Sjögren s Syndrome
* 6.2: Elizabeth J. Price: Musculoskeletal disease - presentation and
management
* 6.3: Rhys Evans and Stephen Walsh: Renal involvement in Primary
Sjögren's Syndrome
* 6.4: Elizabeth J. Price: Gastrointestinal Disease in Sjögren s
syndrome
* 6.5: Aravind Ganesh, Shane Lyons, and Gabriel Yiin: Neurological
complications of Sjögren s Syndrome
* 6.6: Sara Carty: Cardiovascular and Lung Manifestations of Sjögren s
Syndrome
* 6.7: Coziana Ciurtin and Su-Ann Yeoh: Haematological Manifestations
of Sjögren s Syndrome
* 6.8: Coziana Ciurtin and Su-Ann Yeoh: Fatigue in Sjögren s Syndrome
* 6.9: Katie Hackett and Helen Cartner: Non-pharmacological
interventions for the management of Fatigue and Constitutional
Symptoms in Sjögren s Syndrome
* 6.1: Roberta Priori, Antonina Minniti, and Serena Colafrancesco:
Gynaecologic and obstetric aspects in Sjögren s Syndrome
* 6.11: Saad Rassam: Sjögren s Syndrome Associated Lymphoma
* Section 7: Juvenile and young adult
* 7.1: William D. Renton, Elizabeth J. Price, and A.V. Ramanan:
Juvenile and young adult onset Sjögren s Syndrome
* Section 8: Sjogren s mimics and overlaps
* 8.1: Nurhan Sutcliffe: Mimics of Sjögren s Syndrome
* 8.2: Nurhan Sutcliffe and Arabella Waller: Sjögren s Syndrome
overlaps
* Section 9: Experimental treatments, emerging therapies and the future
* 9.1: Benjamin Fisher: Experimental therapies in primary Sjögren s
Syndrome
* 9.2: Elizabeth J. Price and Alan Baer: Sjögren s Syndrome Summary of
Clinical Management
* 1.1: Elizabeth J. Price and Anwar R. Tappuni: Introduction
* 1.2: Caroline Shiboski and Troy E. Daniels: Historical background,
classification and diagnostic criteria
* 1.3: Simon Bowman: Epidemiology and genetics of Sjögren s Syndrome
* Section 2: Basic science
* 2.1: Onorina Berardicurti, Charlotte G. Smith, Roberto Giacomelli,
Elizabeth J. Price, and Francesca Barone: Biomarkers in primary
Sjögren sSyndrome
* 2.2: Aurélie Ambrosi, Albin Björk, and Marie Wahren-Herlenius:
Autoantibodies and autoantigens in Sjögren s Syndrome
* 2.3: Saba Nayar, Serena Colafrancesco, and Francesca Barone: Stromal
cells in Sjögren s Syndrome
* Section 3: Diagnostic investigations
* 3.1: Anwar R. Tappuni: Clinical assessment of salivary glands
function
* 3.2: Benjamin Fisher: Biopsy gland biopsy procedure and
histopathology
* 3.3: Ashok Adams: Imaging in Sjögren s Syndrome
* Section 4: Head and neck manifestations and clinical management
* 4.1: Emily Carter: Salivary glands manifestations and management
* 4.2: Anwar R. Tappuni: Oral manifestations and management
* 4.3: Jennifer Fuller and Shakeel Shahdad: Dental related disease
* Section 5: Ocular manifestations and management
* 5.1: Nicola Roper, Pasquale Aragona, Maurizio Rolando, and Francisco
C Figueiredo: Ocular Manifestations of Sjögren s Syndrome
* 5.2: Nicola Roper, Pasquale Aragona, Maurizio Rolando, and Francisco
C Figueiredo: A therapeutic strategy for Sjögren s Syndrome dry eye
* Section 6: Systemic manifestations
* 6.1: Thomas J Tull, Emma Benton, and David D Cruz: Cutaneous
involvement and management of Sjögren s Syndrome
* 6.2: Elizabeth J. Price: Musculoskeletal disease - presentation and
management
* 6.3: Rhys Evans and Stephen Walsh: Renal involvement in Primary
Sjögren's Syndrome
* 6.4: Elizabeth J. Price: Gastrointestinal Disease in Sjögren s
syndrome
* 6.5: Aravind Ganesh, Shane Lyons, and Gabriel Yiin: Neurological
complications of Sjögren s Syndrome
* 6.6: Sara Carty: Cardiovascular and Lung Manifestations of Sjögren s
Syndrome
* 6.7: Coziana Ciurtin and Su-Ann Yeoh: Haematological Manifestations
of Sjögren s Syndrome
* 6.8: Coziana Ciurtin and Su-Ann Yeoh: Fatigue in Sjögren s Syndrome
* 6.9: Katie Hackett and Helen Cartner: Non-pharmacological
interventions for the management of Fatigue and Constitutional
Symptoms in Sjögren s Syndrome
* 6.1: Roberta Priori, Antonina Minniti, and Serena Colafrancesco:
Gynaecologic and obstetric aspects in Sjögren s Syndrome
* 6.11: Saad Rassam: Sjögren s Syndrome Associated Lymphoma
* Section 7: Juvenile and young adult
* 7.1: William D. Renton, Elizabeth J. Price, and A.V. Ramanan:
Juvenile and young adult onset Sjögren s Syndrome
* Section 8: Sjogren s mimics and overlaps
* 8.1: Nurhan Sutcliffe: Mimics of Sjögren s Syndrome
* 8.2: Nurhan Sutcliffe and Arabella Waller: Sjögren s Syndrome
overlaps
* Section 9: Experimental treatments, emerging therapies and the future
* 9.1: Benjamin Fisher: Experimental therapies in primary Sjögren s
Syndrome
* 9.2: Elizabeth J. Price and Alan Baer: Sjögren s Syndrome Summary of
Clinical Management